Health

Dr. Reddy’s said its US subsidiary, Promius PharmaTM, LLC, has received approval for Sernivo™ (betamethasone dipropionate) Spray, 0.05% from the U.S. Food and Drug Administration (FDA). Sernivo Spray, a prescription topical steroid, is indicated for the treatment of mild to...

Dr. Reddy's Laboratories said the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with...

Venkat says Vyome has become a clinical company in US. The US Food and Drug Administration (US FDA) has accepted Vyome Biosciences’ Investigational New Drug (IND) Application for the initiation of clinical studies for its lead program VB 1953, a...

LifeMap Sciences, Inc., a life sciences technology company and a subsidiary of BioTime, Inc., and MedGenome, Inc, a genomics-based diagnostics and research company, announced on December 2, 2015, a global collaboration agreement. The agreement will strengthen LifeMap’s next generation sequencing...

The Lemon Tree Hotel Group has embarked on a pioneering program to uplift millions of people with socio-economic and physical challenges out of the morass of poverty. This special feature below details on their modus operandi. Many Indians are born...

Hyderabad-based Dr. Reddy's Laboratories has completed the purchase of worldwide exclusive intellectual property rights for Fondaparinux sodium, its generic anti-coagulant drug, from its Australian partner, Alchemia Limited. Earlier, the company had signed a term sheet for this transaction in September,...

Arogya World said myArogya, its new chronic disease prevention mobile App for working Indians, is now available on Android and iOS phones. A formal year-long clinical study in several workplaces is in progress to determine the App’s effectiveness in preventing...

Hyderabad-based Dr. Reddy’s has launched Nise D Spray, emphasizing its strategic intent of being a player of substance in the Indian OTC (Over The Counter) space. Nise D Spray offers quick and targeted pain killing. Through this product Dr. Reddy’s...

Vyome Biosciences has appointed Dr. Bhaskar Chaudhuri, Ph.D. and Alan Rosling to its Board of Directors. , a clinical stage dermatology based innovative biopharmaceutical company, which is pioneering the development of next generation antibiotics and antifungal agents that target antimicrobial...

Dr. Reddy’s Laboratories has signed a commercialization deal with Hatchtech, an Australian pharmaceutical company developing an innovative prescription head lice product, Xeglyze™ Lotion. The exclusive rights for this product are applicable for the territories of the United States, Canada, India,...